PharmaShots Weekly Snapshot (April 08-12, 2019)
Published: April 12, 2019 | Tags: Omron Healthcare, Receives, FDA, Approval, Complete, Blood Pressure, Monitoring, Device, EKG, Facility
2.Gilead and Novo Nordisk Collaborate to Conduct a Combination Therapy Trial in NASH
Published: April 12, 2019 | Tags: Gilead, Novo Nordisk, Collaborate, Conduct, Combination Therapy, Trial, NASH
Published: April 12, 2019 | Tags: ?Moleculin, Signs, Clinical, Research, Agreement, Emory University, WP1066, Brain Tumor, Pediatric Patients
Published: April 12, 2019 | Tags: Evotec, Sign, Research, Agreement, Indivumed, Develop, Precision, Therapies, Colorectal Cancer, CRC
Published: April 12, 2019 | Tags: Merck, Keytruda, pembrolizumab, Receives, FDA, Expanded, Monotherapy, Label, Approval, Patients, 1L, Stage III, Non-Small Cell Lung Cancer, NSCLC
Published: April 11, 2019 | Tags: BioDelivery Sciences, BDSI, Signs, License, Agreement, Shionogi, Commercialize, Symproic, naldemedine, the US
Published: April 11, 2019 | Tags:Cognoa, Signs, Exclusive, License, Agreement, Stanford, Google Glass-based Technology, Children, Autism Spectrum Disorder, ASD
8.Sandoz Signs a Commercialization Agreement with Shionogi for Rizmoic (naldemedine) in Europe
Published: April 11, 2019 | Tags: Sandoz, Collaborates, Shionogi, Commercialize, Rizmoic, naldemedine
9. Shanghai Miracogen Signs a Non-Exclusive License Agreement with Synaffix for its ADC Technologies
Published: April 11, 2019 | Tags: Shanghai Miracogen, Signs, Non-Exclusive, License, Agreement, Synaffix, ADC Technologies
Published: April 11, 2019 | Tags: Astellas, Collaborates, Concerto HealthAI, Real-World Evidence, RWE, Initiative, Acute Myeloid Leukemia, AML
11.Shanghai Fosun Signs an Exclusive License Agreement with ReNeuron for its CTX and hRPC Cell Therapy in China
Published: April 10, 2019 | Tags: Shanghai Fosun, Signs, Exclusive, License, Agreement, ReNeuron, CTX, hRPC, Cell Therapy ?
Published: April 10, 2019 | Tags: Alkermes, Reports, Results, Aristada, aripiprazole lauroxil, Invega Sustenna, paliperidone palmitate, P-IIIb, ALPINE Study, Treat, Schizophrenia
Published: April 10, 2019 | Tags: AstraZeneca, Merck, Lynparza, olaparib, Receives, EU, Approval, Monotherapy, Treat, Germline, BRCA-Mutated, HER2-Negative, Advanced, Breast Cancer
14. Xinhua Healthcare Signs an Exclusive License Agreement with ArcDia for its mariPOC Technology in China
Published: April 10, 2019 | Tags: Xinhua Healthcare, Signs, Exclusive, License, Agreement, ArcDia, mariPOC, technology, China
Published: April 10, 2019 | Tags: Amgen, Evenity, romosozumab-aqqg, Receives, FDA, Approval, Osteoporosis, Postmenopausal Women, High Risk, Fracture
Published: April 09, 2019 | Tags: BeiGene, Signs, Worldwide, Co-Development, Commercialization, Agreement, BioAtla, BA3071, Tislelizumab
17. Audentes Signs an Exclusive License Agreement with Nationwide Childrens Hospital (NCH) for the Expansion of its AAV Technology and Pipeline
Published: April 09, 2019 | Tags: Audentes, Collaborates, Nationwide Children's Hospital, Expansion, AAV Technology, Pipeline
18. uniQures AMT-130 Receives FDAs Fast Track Designation for Huntingtons Disease
Published: April 09, 2019 | Tags: uniQure, AMT-130, Receives, FDA, Fast Track Designation, Huntingtons Disease
Published: April 09, 2019 | Tags: GSK, Dovato, dolutegravir/lamivudine, Receives, FDA, Approval, Treat, HIV-1, infection, Adults
20.Regeneron Collaborates with Alnylam to Discover, Develop and Commercialize RNAi Therapeutics for Ophthalmic and CNS Disorders
Published: April 09, 2019 | Tags: Regeneron, Collaborates, Alnylam, Discover, Develop, Commercialize, RNAi Therapeutics, Ophthalmic, CNS Disorders
21. Xoma Purchases Royalty Rights for Aronoras Five Preclinical and Clinical Hematology Candidates
Published: April 08, 2019 | Tags: Xoma, Purchases, Aronora, Royalty, Rights, Five, Hematology Candidates
22.Sanofi and Alnylam Exercise Research and Option Phase Collaboration for its 2014 Deal
Published: April 08, 2019 | Tags: Sanofi, Alnylam, Exercise, Research, Option, Phase, Collaboration, Rare Diseases, 2014
Published: April 08, 2019 | Tags: Celgene, Acceleron, Submit, Biologics License Application, US FDA, Luspatercept
Published: April 08, 2019 | Tags: AVITA Medical, Reports, Results, RECELL System, Investigational Device Exemption, IDE, Compassionate Use, Continued Access Studies, Third-Degree Burns, Pediatric Patients